By Marie Schiller, Arushi Agarwal, and Sheela Hegde (Health Advances)
Published in the August 12, 2015 Issue (Vol. 2, No. 14)
Simple insulin infusers are emerging as an important new tool to help people with type 2 diabetes gain better control of their disease. Although only one simple infuser product has been approved in the US to date, more are on the way and interest among physicians and payors is on the rise—all of which suggests a budding new market opportunity in the years ahead.
Sidebar: “CeQur: Overcoming Barriers with PaQ Simple Insulin Infuser”
CeQur is moving toward commercialization of the PaQ insulin infuser to address barriers to insulin use among patients with type 2 diabetes.
Bigfoot Biomedical – Cellnovo – CeQur SA – Debiotech SA – Health Advances – Insulet – Johnson & Johnson – Mannkind – Medtronic PLC – Roche – Tandem Diabetes Care – Valeritas